Multitarget Potential Drug Candidates for High-Grade Gliomas Identified by Multiple Reaction Monitoring Coupled with <i>In Silico</i> Drug Repurposing-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Multitarget Potential Drug Candidates for High-Grade Gliomas Identified by Multiple Reaction Monitoring Coupled with In Silico Drug Repurposing

Published:2024-02-06 Issue: Volume: Page:
ISSN:1557-8100
Container-title:OMICS: A Journal of Integrative Biology
language:en
Short-container-title:OMICS: A Journal of Integrative Biology

Author:

Verma Ayushi¹,Patel Rushda²,Mahale Atharva³,Thorat Rujuta Vijay⁴,Rath Soumya Lipsa⁵,Sridhar Epari⁶,Moiyadi Aliasgar⁶,Srivastava Sanjeeva¹^ORCID

Affiliation:

1. Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Powai, Mumbai, India.

2. Sinhgad College of Pharmacy, Savitribai Phule Pune University, Pune, India.

3. Department of Biological Sciences, Indian Institute of Science Education and Research Kolkata, Mohanpur, West Bengal, India.

4. School of Biosciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, India.

5. Department of Biotechnology, National Institute of Technology, Warangal, India.

6. Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine,Biochemistry,Biotechnology

Link

https://www.liebertpub.com/doi/pdf/10.1089/omi.2023.0256

Reference68 articles.

1. Molecular insight of regorafenib treatment for colorectal cancer

2. Major Challenges and Potential Microenvironment-Targeted Therapies in Glioblastoma

3. Glioblastoma vs temozolomide: can the red queen race be won?

4. Toxicity Profile of Temozolomide in the Treatment of 300 Malignant Glioma Patients in Korea

5. Integrative Proteomic and Pharmacological Analysis of Colon Cancer Reveals the Classical Lipogenic Pathway with Prognostic and Therapeutic Opportunities

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3